1. EUDA launches Helixé 2.0, enhancing formulation and delivery technology. 2. 20% increase in deer placenta powder reinforces product potency. 3. New Zealand Halal certification enables access to wider markets. 4. Upgraded packaging and branding improve product's market presence. 5. Helixé 2.0 aligns with EUDA's global expansion strategy.
FAQ
Why Bullish?
The improvements to Helixé 2.0 significantly strengthen EUDA's market position, similar to past successful product launches. Historical performance indicates that successful product upgrades often result in increased stock prices.
How important is it?
The article provides crucial insights into product enhancement and global expansion which are significant growth drivers for EUDA.
Why Long Term?
The global expansion and market readiness may take time to materialize but offer substantial future growth, akin to EUDA's past initiatives targeting longevity markets.
EUDA Health to Launch EUDA Helixé 2.0 in January 2026
SINGAPORE, Dec. 29, 2025 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA), a Singapore-based leader in non-invasive healthcare in Asia, has announced plans to launch EUDA Helixé 2.0 in January 2026. This significant upgrade of its flagship youthful vitality and longevity supplement includes extensive enhancements in formulation, ingredient technology, and market readiness.
Strengthened Formula and Ingredient Optimization
EUDA Helixé 2.0 introduces a 20% increase in New Zealand-sourced deer placenta powder, boosting the dosage from 100 mg to 120 mg. This improvement reinforces EUDA’s commitment to high potency in vitality formulations. Additionally, the new formula replaces L-glutathione with D-alpha-tocopherol (Vitamin E, 1.4 mg equivalent), designed to enhance antioxidant stability and support skin health, aligning with long-term wellness and anti-aging goals.
Advanced Encapsulation and Preservation Technology
The product features an upgraded preservation and delivery platform that enhances absorption efficiency and extends shelf life:
- Freeze Drying: Preserves nutrient potency while removing moisture.
- Refining Technology: Enhances stability and minimizes allergenic reactions.
- Nitrogen Encapsulation: Reduces oxidation, extending shelf life.
- Nano Emulsification: Improves solubility and nutrient delivery efficiency.
This advanced delivery system allows for smaller capsule sizes, improving user experience while enhancing nutrient absorption.
New Proprietary Bottle Design
In conjunction with the product upgrade, EUDA is unveiling a proprietary bottle design for EUDA Helixé that emphasizes its premium positioning. This new design enhances product protection and shelf presence, reinforcing brand identity.
New Zealand Halal Certification and Global Market Expansion
Pending the January 2026 launch, EUDA Helixé 2.0 has secured New Zealand Halal certification. This certification paves the way for broader international distribution, particularly into Muslim markets across Southeast Asia and the Middle East.
Positioning EUDA Helixé for Global Growth
The upcoming launch highlights EUDA Health’s dedication to continuous innovation and scalable wellness solutions. With enhanced formulation strength and refined packaging, EUDA Helixé 2.0 aims to be a cornerstone in EUDA’s expanding health and longevity ecosystem.
Mr. Alfred Lim, CEO of EUDA, stated: “This marks an important milestone in EUDA’s product evolution. With EUDA Helixé 2.0, we are upgrading delivery technology and expanding global market accessibility. These enhancements reflect our commitment to science-backed innovation and align EUDA Helixé as a premium longevity supplement in our broader strategy.”
About EUDA Health Holdings Limited
EUDA Health Holdings Limited (NASDAQ: EUDA) is a Singapore-based healthcare provider focused on non-invasive and preventive care, specifically targeting Singapore, Malaysia, and China. The company is dedicated to addressing the healthcare needs of over 1.8 billion people in the region, responding to significant demographic changes as over 30% of the population ages rapidly.
Forward-Looking Statements
This announcement may contain forward-looking statements regarding risks and uncertainties. These statements use words such as “estimates,” “projects,” and “anticipates,” which are not guarantees of future performance but are subject to various risks. Stakeholders are advised not to overly rely on these forward-looking statements.
Contact Information
For further inquiries, please contact:
Christensen Advisory
Linda Bergkamp
Phone: +1-480-614-3004